Loading...
Loading...
BNTC| Name | Value |
|---|---|
| Revenues | 0.0K |
| Cost of Revenue | 81.0K |
| Gross Profit | -81.0K |
| Operating Expense | 8,610.0K |
| Operating I/L | -8,610.0K |
| Other Income/Expense | 1,253.0K |
| Interest Income | 823.0K |
| Pretax | -7,357.0K |
| Income Tax Expense | 0.0K |
| Net Income/Loss | -7,357.0K |
Benitec Biopharma Inc. is a biotechnology company specializing in the development of DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. The company's main focus is on developing gene therapy agents such as BB-301 for treating oculopharyngeal muscular dystrophy and BB-103 for chronic hepatitis B virus infection.
